Enhabit, Inc.

EHAB

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Deerfield Management

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Deerfield ManagementNEWFeb 17, 2026

Shares: 4,747,746Value: $43.8M

# Signal Note: Deerfield Initiates $43.8M Position in Enhabit (EHAB) Deerfield's new 4.7M-share stake suggests conviction in Enhabit's home health/post-acute care platform amid favorable reimbursement tailwinds and operational leverage potential. The timing aligns with industry consolidation momentum and potential margin expansion as the company scales, though investors should monitor Medicare payment adjustments and patient acuity trends that could impact utilization rates.

More EHAB Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

RDNT1 fund VTR1 fund PHVS1 fund PMVP1 fund ALHC1 fund ATRC1 fund BCRX1 fund NBIX

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: